Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Baricitinib is effective as a treatment for severe hair loss.

Selencin effectively reduces hair loss and improves hair health in diffuse alopecia.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

The new patch for treating mouth sores releases medicine slowly, sticks well, and helps healing without the side effects of current creams.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Researchers developed a new skin patch that delivers more finasteride into the skin, potentially improving treatment for hair loss and prostate issues.

JAK inhibitors are effective treatments for alopecia areata.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Ruxolitinib helped a patient with alopecia areata regrow hair.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

New treatments for lupus show promise, but more research is needed, especially for children.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

A woman with lupus developed rare skin growths that went away on their own.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.